Neogen Corp (NEOG)
14.98
+0.40
(+2.74%)
USD |
NASDAQ |
Nov 22, 16:00
14.97
-0.01
(-0.07%)
After-Hours: 20:00
Neogen Enterprise Value: 4.015B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 4.015B |
| November 21, 2024 | 3.928B |
| November 20, 2024 | 3.997B |
| November 19, 2024 | 4.039B |
| November 18, 2024 | 4.062B |
| November 15, 2024 | 3.932B |
| November 14, 2024 | 3.941B |
| November 13, 2024 | 4.058B |
| November 12, 2024 | 4.093B |
| November 11, 2024 | 4.323B |
| November 08, 2024 | 4.286B |
| November 07, 2024 | 4.188B |
| November 06, 2024 | 4.153B |
| November 05, 2024 | 4.023B |
| November 04, 2024 | 3.896B |
| November 01, 2024 | 3.898B |
| October 31, 2024 | 3.863B |
| October 30, 2024 | 3.926B |
| October 29, 2024 | 3.876B |
| October 28, 2024 | 3.813B |
| October 25, 2024 | 3.761B |
| October 24, 2024 | 3.711B |
| October 23, 2024 | 3.746B |
| October 22, 2024 | 3.800B |
| October 21, 2024 | 3.813B |
| Date | Value |
|---|---|
| October 18, 2024 | 3.911B |
| October 17, 2024 | 3.902B |
| October 16, 2024 | 3.935B |
| October 15, 2024 | 3.961B |
| October 14, 2024 | 3.807B |
| October 11, 2024 | 3.896B |
| October 10, 2024 | 3.757B |
| October 09, 2024 | 3.987B |
| October 08, 2024 | 3.952B |
| October 07, 2024 | 3.995B |
| October 04, 2024 | 4.034B |
| October 03, 2024 | 4.006B |
| October 02, 2024 | 4.173B |
| October 01, 2024 | 4.149B |
| September 30, 2024 | 4.411B |
| September 27, 2024 | 4.368B |
| September 26, 2024 | 4.381B |
| September 25, 2024 | 4.336B |
| September 24, 2024 | 4.442B |
| September 23, 2024 | 4.546B |
| September 20, 2024 | 4.552B |
| September 19, 2024 | 4.567B |
| September 18, 2024 | 4.505B |
| September 17, 2024 | 4.424B |
| September 16, 2024 | 4.309B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.826B
Minimum
Aug 24 2022
5.797B
Maximum
Aug 15 2023
3.864B
Average
3.985B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.27B |
| Biogen Inc | 27.60B |
| Dynavax Technologies Corp | 1.092B |
| Repligen Corp | 7.726B |
| Xencor Inc | 1.222B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.61M |
| Revenue (Quarterly) | 216.96M |
| Total Expenses (Quarterly) | 214.71M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 48.36% |
| Profit Margin (Quarterly) | -5.81% |
| Earnings Yield | -0.77% |
| Operating Earnings Yield | 1.29% |
| Normalized Earnings Yield | -0.6818 |